Searched for
PFIZER PAXLOVID
Hetero gets WHO prequalification for generic Covid antiviral PaxlovidThis is the first WHO prequalification for Paxlovid - a combination of nirmatrelvir and ritonavir which is recommended for treating mild an...- Pfizer CEO tests positive for COVID for a second timePfizer Chief Executive Officer Albert Bourla , 60, back in August had contacted COVID and had started a course of the company's oral COVID-...
- Pfizer CEO Albert Bourla tests positive for Covid, says has very mild symptomsPfizer Inc Chief Executive Officer Albert Bourla said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid,...
- Drugmakers seem to be in no hurry to launch Covid antiviral pill PaxlovidSeveral industry executives and doctors ET spoke to said at the moment, while cases are rising, the need for Paxlovid hasn't been felt as c...
- Rare cases of COVID returning pose questions for Pfizer pillPaxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disea...
- ICMR task force meets to discuss inclusion of Pfizer’s Paxlovid for Covid treatmentPfizer’s Paxlovid contains Nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and Ritonavir, which slows...
- World Health Organization 'strongly recommends' Pfizer's COVID-19 pillUS pharma giant Pfizer's combination of nirmatrelvir and ritonavir was the "superior choice" of treatment for unvaccinated, elderly or immu...
- 19 Indian companies get licence to make Pfizer's oral genericThese include Cipla, Sun Pharma, Laurus Labs, Divi's Laboratories, Glenmark, Emcure, Macleods, SMS Pharmaceuticals, Strides, Torrent, Cadil...
- Cipla to conduct study on PaxlovidIn its meeting held this week, the SEC granted approval to the company to conduct bioavailability and bio equivalence (BA/BE) studies. “Cip...
- Nod for Paxlovid's Indian generic version to take longerHetero Labs and Optimus Pharma had approached the drug regulatory authority last month seeking waivers from conducting local trials. Howeve...
- China approves use of Pfizer's COVID drug PaxlovidThe National Medical Products Administration said Paxlovid is approved to treat adults who have mild to moderate COVID-19 and high risk of ...
- Pfizer plans tiered pricing for its Covid antiviral PaxlovidPfizer has signed a voluntary licensing with UN-backed Medicines Patent Pool (MPP) allowing the latter to grant sub-licences of Paxlovid to...
- Pfizer's COVID product sales to top $50 billion this year, investors want moreAlthough Pfizer raised its forecast for the vaccine, developed with Germany's BioNTech SE, by $1 billion to $32 billion, the drugmaker caut...
- Pfizer may offer Covid antiviral drug to India at lower price for nowPfizer has entered into advance purchase agreements with multiple countries. Sources told ET that Pfizer is yet to apply for emergency use ...
- Bangladeshi firm launches first generic of Pfizer drugBangladesh's directorate general of drug administration on Thursday granted emergency use authorisation for the oral antiviral drug to trea...
- US nod in Hand, Pfizer is looking for partners to make Covid drug in IndiaThe company has begun investing $1 billion, at risk, in the manufacture of its potential Covid-19 oral antiviral drug with the goal of maki...
- Pill 88% effective if given early, says PfizerFinal results of Paxlovid demonstrated reduction of hospitalisation or death by 89% among high-risk patients treated within three days of s...
- Pfizer says antiviral pill cut hospitalisation by 89%, neutralised Omicron in lab testsThe company said the 88% efficacy in patients treated within five days of symptom onset, was an increase from the 85% observed in the inter...
- Local firms gear up to seek licence for Pfizer's Covid drugUS drug giant Pfizer on Tuesday announced a deal with MPP - a UN-backed public health organization - to issue royalty-free voluntary licenc...
- Pfizer enters deal with UN-backed MPP to license COVID drug in 95 countries including IndiaPfizer said it will waive royalties on sales in all countries covered by the agreement while COVID-19 remains classified as a Public Health...
Load More
